Praxis Precision Medicines (PRAX) Accumulated Expenses (2019 - 2026)

Praxis Precision Medicines' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $17.6 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 13.51% year-over-year to $17.6 million in Q1 2026; TTM through Mar 2026 was $17.6 million, a 13.51% increase from a year earlier, with the FY2025 full-year figure at $35.0 million, up 47.43% from the prior year.
• Accumulated Expenses fell to $17.6 million in Q1 2026 per PRAX's latest filing, from $35.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $35.0 million in Q4 2025 and bottomed at $7.0 million in Q1 2024.
• The 5-year median for Accumulated Expenses is $15.8 million (2022), against an average of $17.2 million.
• Across the five-year window, Accumulated Expenses soared 318.75% in 2022 and slumped 69.76% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $15.8 million in 2022, then tumbled by 53.21% to $7.4 million in 2023, then jumped by 220.43% to $23.8 million in 2024, then soared by 47.43% to $35.0 million in 2025, then sank by 49.62% to $17.6 million in 2026.
• Per Business Quant, the three latest PRAX Accumulated Expenses figures stand at $17.6 million (Q1 2026), $35.0 million (Q4 2025), and $21.6 million (Q3 2025).